PTC Therapeutics, Inc. (BX:P91) Financings
Financings
| Raise | Date |
|---|---|
| 0% Convertible Senior Notes due 2031 Update: US$500M Use of proceeds: About $328.8 million to repurchase 2026 convertible notes; rest for general corporate purposes, including further repurchases or repayment of 2026 notes | Jun 16, 2026 |